Status:
NOT_YET_RECRUITING
Dual-Energy Computed Tomography for Improving Imaging Assessment of Multiple Myeloma
Lead Sponsor:
Guy's and St Thomas' NHS Foundation Trust
Conditions:
Myeloma
Eligibility:
All Genders
18+ years
Brief Summary
Up to 30% of patients with newly diagnosed/suspected myeloma cannot undergo or do not tolerate whole body MRI (WB-MRI). A number of factors may be contributory. First, WB-MRI protocols can take in exc...
Eligibility Criteria
Inclusion
- Adults with suspected or newly diagnosed myeloma
Exclusion
- No previous treatment for myeloma
- No concurrent cancer elsewhere
- No contraindications to CT or MRI scans
- Routine, standard of care cut-off for minimum renal function (eGFR \> 40 ml/min/1.73 m2) in order to receive IV gadolinium-based contrast media.
Key Trial Info
Start Date :
June 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
78 Patients enrolled
Trial Details
Trial ID
NCT05353907
Start Date
June 1 2022
End Date
December 1 2026
Last Update
April 29 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.